Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Senior VP, Chief Pharma Dev.
-
Stock Symbol
-
MDGL on Nasdaq
Robert E. Waltermire - trading volume in the past year for Madrigal Pharmaceuticals, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
5.5K |
$1.54M |
$280.00 |
Jun 14, 2024 |
Direct |
|
|
| Market Stock Unit |
1.42K |
$346K |
$243.92 |
Jan 23, 2024 |
Direct |
Common Stock |
|
| Stock Option (Right to Buy) |
10.4K |
|
|
Jun 14, 2024 |
Direct |
Common Stock |
$1.9K |
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.